关于炎症性肠病与 Clostridioides difficile 感染之间的关系的遗传洞察
Kelly C Cushing-Damm1, Yanhua Chen1, Xiaomeng Du1
1Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.
mSphere
|October 22, 2024
概括
在炎症性肠病 (IBD) 患者中,遗传因素增加了Clostridioides difficile感染 (CDI) 的风险. 这项研究确定了一种遗传联系,解释了IBD中较高的CDI率,特别是性结肠炎.
科学领域:
- 遗传学 是一个遗传学.
- 传染病流行病学 传染病流行病学
- 免疫学 免疫学 免疫学
背景情况:
- 患有炎症性肠病 (IBD) 的患者表现出更高的Clostridioides difficile感染 (CDI) 发病率.
- 这种关联的根本原因,特别是宿主遗传学的作用,仍然不完全理解.
- 研究遗传倾向可以阐明共同的风险因素,并为治疗策略提供信息.
研究的目的:
- 调查遗传因素是否有助于IBD患者中观察到的CDI风险增加.
- 为了确定与CDI易感性相关的特定遗传变异.
- 使用孟德尔随机化来确定IBD和CDI之间的因果关系.
主要方法:
- 全基因组关联研究 (GWAS) 使用密歇根基因组学倡议和英国生物银行数据进行.
- 用公开可用的GWAS总结统计数据 (芬兰生物库) 对CDI进行了元分析.
- 采用双样本门德尔随机化 (MR) 评估IBD对CDI风险的因果关系.
主要成果:
- 与CDI相关的全基因组显著变异 (rs3134745) 在主要组织相容性复杂区域内被确定.
- 精细映射表明了HLA-B*35:01等位基因的潜在作用.
- 基因预测IBD,特别是性结肠炎,因果关系与CDI风险增加有关 (OR 1.16-1.22).
结论:
- 遗传易感性在CDI的发病过程中起着重要作用,特别是在IBD患者中.
- 这项研究为患有炎症性肠道疾病的个体中CDI风险升高提供了遗传解释.
- 这些发现支持探索宿主导疗法,如抗干白素-23剂,用于ICD的CDI预防和治疗.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
189
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189
Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Irritable Bowel Syndrome I: Introduction
252
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
252
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Chronic Bowel Disorders: Introduction
394
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
394


